מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
Flecainide acetate
iNova Pharmaceuticals Australia Pty Ltd
Medicine Registered
TAMBOCOR(TM) 1 TAMBOCOR(TM) (tam-bo-core) _Flecainide acetate (fleck-ain-ide ass-e-tate)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Tambocor tablets and injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risk of you taking or being given Tambocor against the benefits it can have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING OR HAVING THIS MEDICINE PLEASE SPEAK TO YOUR DOCTOR, NURSE OR PHARMACIST. KEEP THIS LEAFLET. You may want to read it again. WHAT TAMBOCOR IS USED FOR Tambocor is used to treat a heart condition called arrhythmia. Arrhythmia is an irregular or abnormal heart beat. The active ingredient in Tambocor, flecainide acetate, belongs to a group of drugs called antiarrhythmic medicines which slow down the impulses that cause the heart to beat in an irregular or abnormal way. Your doctor may have prescribed Tambocor for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. BEFORE USING OR BEING GIVEN TAMBOCOR _WHEN YOU MUST NOT USE OR_ _HAVE TAMBOCOR_ DO NOT USE OR HAVE TAMBOCOR IF YOU HAVE AN ALLERGY TO: * flecainide acetate * any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: * shortness of breath * wheezing or difficulty breathing * swelling of the face, lips, tongue or other parts of the body * rash, itching or hives on the skin DO NOT GIVE TAMBOCOR TO CHILDREN. DO NOT TAKE OR HAVE THIS MEDICINE: * if you have severe heart, liver or kidney disease unless your doctor says it is suitable for you * after the 'USE BY' date. The 'USE BY' date can be found on the box and tablet blister. For the injection this can be found on the box and vial label * if קרא את המסמך השלם
iaptambo10808.doc - 1 - PRODUCT INFORMATION TAMBOCOR ™ TABLETS 50MG, 100MG & INJECTION 150MG NAME OF THE MEDICINE NON-PROPRIETARY NAME: Flecainide Acetate CHEMICAL STRUCTURE: DESCRIPTION: Flecainide acetate; N-(2-piperidinylmethyl)-2, 5-bis (2,2,2-trifluoroethoxy) benzamide acetate, belongs to the benzamide class of antiarrhythmic drugs and is structurally related to lignocaine and procainamide. It is chemically distinguished from these agents by the presence of trifluoroethoxy- substituents in the aromatic portion of the molecule and a piperidine ring in the amide side chain instead of the diethylaminoethyl group of the procainamide side chain. The compound is a racemic mixture. It is soluble in water, dilute acetic acid, methanol and ethanol and practically insoluble in dilute hydrochloric acid. It has a molecular formula of C17H20F6N2O3.C2H4O2 and a molecular weight of 474.4; CAS No: 54143-56-5. EXCIPIENTS: Tablets Pregelatinised Maize Starch; Croscarmellose Sodium; Microcrystalline Cellulose; Hydrogenated Vegetable Oil; Magnesium Stearate. Injection Sodium Acetate; Glacial Acetic Acid. PHARMACOLOGY PHARMACOLOGY: TAMBOCOR belongs generally to the membrane stabilising (Class 1) group of antiarrhythmic agents, however, it has its own characteristic electrophysiological effects. Its predominant effect on the transmembrane action potential in single cell preparations from canine Purkinje fibres is to decrease the rate of rise (V max, Phase 0) of the action potential without greatly affecting duration. In these same preparations, the duration of the effective refractory period was lengthened and little, if any, change was observed in the slope of Phase 4 depolarization. In ventricular muscle, some lengthening of the action potential duration has been observed. These results קרא את המסמך השלם